Conjugation of methoxypolyethylene glycol to the surface of bovine red blood cells

Biotechnology and Bioengineering

Volumn 96, Issue 6, 2007, Pages 1199-1210

  Gundersen, Sharon I ^a   Parmer, Andre F ^a  

^a UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

Bovine red blood cells; Methoxypoly(ethylene glycol); Stealth erythrocytes; Transfusion

Indexed keywords

BLOOD TRANSFUSION; IMMUNOLOGICAL RECOGNITION; METHOXYPOLYETHYLENE GLYCOL; RED BLOOD CELLS;

ANTIGENS; BINDING SITES; BLOOD; COVALENT BONDS; TISSUE; VISCOSITY;

POLYETHYLENE GLYCOLS;

BLOOD SUBSTITUTE; MACROGOL; METHOXYPOLYETHYLENE GYCOL; PROPIONIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD RHEOLOGY; CONTROLLED STUDY; ERYTHROCYTE ADHESIVENESS; ERYTHROCYTE TRANSFUSION; NONHUMAN; OXYGEN TRANSPORT; SIMULATION;

ANIMALS; BLOOD SUBSTITUTES; CATTLE; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; HUMANS; OXYGEN; POLYETHYLENE GLYCOLS; RHEOLOGY;

BOVINAE;

EID: 34247525975     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.21204     Document Type: Article

References (39)

1. Armstrong JK, Meiselman HJ, Fisher TC. 1997. Covalent binding of poly(ethylene glycol) (PEG) to the surface of red blood cells inhibits aggregation and reduces low shear blood viscosity. Am J Hematol 56:26-28.
2. Biopure. 2004. Biopure annual report 2004. http://www.biopure.com/ corporate/reports/ar04/page5.htm (accessed on May 26, 2005).
3. Birkenmeier G, Walter H, Widen KE. 1994. Factors in the affinity extraction of red blood cells using poly(ethylene glycol)-metal chelate. Methods Enzymol 228:368-390.
4. Blackall DP, Armstrong JK, Meiselman HJ, Fisher TC. 2001. Polyethylene glycol-coated red blood cells fail to bind glycophorin A-specific antibodies and are impervious to invasion by the Plasmodium falciparum malaria parasite. Blood 97:551-556.
5. Bonsen P, Laver MB, Morris KC, Alza Corporation, assignee. 1977. Novel polymerized, cross-linked, stromal-free hemoglobin. United States patent 4,001,200.
6. Bradley AJ, Test ST, Murad KL, Mitsuyoshi J, Scott MD. 2001. Interactions of IgMABO antibodies and complement with methoxy-PEG-modified human RBCs. Transfusion 41:1225-1233.
7. Bradley AJ, Murad KL, Regan KL, Scott MD. 2002. Biophysical consequences of link chemistry and polymer size on stealth erythrocytes: Size does matter. Biochim Biophys Acta 1561:147-158.
8. Davey RJ. 2004. Overcoming blood shortages: Red blood cell and platelet substitutes and membrane modifications. Curr Hematol Rep 3(2):92-96.
9. 4 concentration and reaction time on physical properties of glutaraldehyde-polymerized hemoglobin. Biotechnol Prog 20(3):946-952.
10. Fournier RL. 1999. Basic transport phenomena in biomedical engineering. Philadelphia: Taylor & Francis.
11. Garratty G, Telen M, Petz LD. 2002. Red cell antigens as functional molecules and obstacles to transfusion. Hematology 2002:445-462.
12. Gavasane MR, Gaikar VG. 2003. Aqueous two-phase affinity partitioning of penicillin acylase from E. coli in presence of PEG-derivatives. Enzyme Microb Technol 32:665-675.
13. Gordon JE, Dare MR, Palmer AF. 2005. Engineering select physical properties of cross-linked red blood cells and a simple a priori estimation of their efficacy as an oxygen delivery vehicle within the context of a hepatic hollow fiber bioreactor. Biotechnol Prog 21(6):1700-1707.
14. Harris JM, Kozlowski A, Shearwater Polymers, Inc., assignee. 1995. Poly(-ethylene glycol) and related polymers monosubtituted with propionic or butanoic acids and functional derivatives thereof for Biotechnical Applications. Patent 5672662 (9/30/1997).
15. Harrison L, Blackwell K. 2004. Hypoxia and anemia: Factors in decreased sensitivity to radiation therapy and chemotherapy? Oncologist 9:31-40.
16. Holmberg K, Bergstrom K, Brink C, Osterberg E, Tiberg F, Harris JM. 1993. Effects on protein adsorption, bacterial adhesion and contact-angle of grafting PEG chains to polystyrene. J Adhes Sci Technol 7(6):503-517.
17. Jo S, Park K. 2000. Surface modification using silanated poly(ethylene glycol)s. Biomaterials 21:605-616.
18. Johnstone JE, MacLaren LA, Doucet J, McAlister VC. 2004. In vitro studies regarding the feasibility of bovine erythrocyte xenotransfusion. Xenotransplantation 11(1):11-17.
19. King MR, Leighton DT. 2001. Measurement of shear-induced dispersion in a dilute emulsion. Phys Fluids 13(2):397-406.
20. Lutwyche P, Norris-Jones R, Brooks DE. 1995. Aqueous two-phase polymer systems as tools for the study of recombinant surface-expressed Escherichia Coli hemagglutinin. Appl Environ Microbiol 61(9):3251-3255.
21. McCarthy MR, Vandegriff KD, Winslow RM. 2001. The role of facilitated diffusion in oxygen transport by cell-free hemoglobins: implications for the design of hemoglobin-based oxygen carriers. Biophysical Chemistry 92:103-117.
22. Micks W. 2005. Quad Five's collection and virus screening. Ryegate, MT: Fax transmittal received by S. Gundersen on 5/16/2005.
23. Murad KL, Mahany KL, Brugnara C, Kuypers FA, Eaton JW, Scott MD. 1999. Structural and functional consequeces of antigenic modulation of red blood cells with methoxypoly(ethylene glycol). Blood 93(6):2121-2127.
24. Nektar Therapeutics. 2006. Polyethylene glycol and derivatives for Advanced PEGylation Catalog 2005-2006. http://www.nektar.com/ (accessed on 06/14/2006).
25. Otchet A. 2001. Animal transplants: Safe or sorry? UNESCO Courier. http://www.unesco.org/courier/2000_3/uk/ethique/txt1.htm (accessed on 6/7/2004).
26. Phillips WT, Klipper RW, Awasthi VD, Rudolph AS, Cliff R, Kwasiborski V, Coins BA. 1999. Polyethylene glycol-modified liposome-encapsulated hemoglobin: A long circulating red cell substitute. J Pharmacol Exp Ther 288(2):665-670.
27. Quad 5. Quad 5 Animal diagnostic blood products. http.V/www.quadfive.com/ (accessed on May 15. 2002). Circular of Information for the Use of Human Blood and Blood Components. South Bend Medical Foundation, Inc., editor: American Association of Blood Banks, America's Blood Centers, & American Red Cross. p 1-39.
28. Riess JG. 2001. Oxygen carriers ("blood substitutes") - raison d'etre, chemistry, and some physiology. Chem Rev 101(9):2797-2919.
29. Scott MD, Murad KL, Koumpouras F, Talbot M, Eaton JW. 1997a. Chemical camouflage of antigenic determinants: Stealth erythrocytes. Proc Natl Acad Sci 94:7566-7571.
30. Scott MD, Kucik DF, Goodnough LT, Monk TG. 1997b. Blood substitutes: Evolution and future applications. Clin Chem 43(9):1724-1731.
31. Scott MD, Bradley AJ, Murad KL. 2000. Camouflaged blood cells: Low-technology bioengineering for transfusion medicine. Transfus Med Rev 14(1):53-63.
32. Scott MD, Chen AM. 2004. Beyond the red cell: pegylation of other blood cells and tissues. Transfusion Clinique et Biologique 11:40-46.
33. Sullivan JP, Gordon JE, Palmer AF. 2006. Simulation of oxygen carrier mediated oxygen transport to C3A hepatoma cells housed within a hollow fiber bioreactor. Biotechnol Bioeng 93(2):306-317.
34. Vadapalli A, Goldman D, Popel AS. 2002. Calculation of oxygen transport by red blood cells and hemoglobin solutions in capillaries. Artif Cells Blood Substit Immobil Biotechnol 30(3):157-188.
35. Vaupel P. 2004. The role of hypoxia-induced factors in tumor progression. Oncologist 9(Suppl 5):10-17.
36. Voet D, Voet JG. 1995. Biochemistry. New York: John Wiley & Sons, Inc.
37. Williams RD. 1996. Organ transplants from animals: Examining the possibilities. FDA Consumer Magazine 30(5). http://www.fda.gov/fdac/features/ 596_xeno.html (accessed on 6/7/2004).
38. Zhou R, Chang H-C. 2005. Wetting penetration failure of blood suspensions. J Colloid Interface Sci 287:647-656.
39. Zhou RH, Gordon J, Palmer AF, Chang HC. 2006. Role of erythrocyte deformability during capillary wetting. Biotechnol Bioeng 93(2):201-211.